In summary, this study demonstrates that miR‐217 acts as a critical regulatory factor in the biology of DCIS cells by targeting DNMT1, inhibiting methylation of the TSHZ2 promoter region, and suppressing the Hedgehog‐GLI signaling pathway. This evidence concerns the gene TSHZ2 and ductal breast carcinoma in situ.